Damage Control Resuscitation und Damage Control Surgery

Nach Abschluss des „Primary Survey“ eines Schwerverletzten muss im Schockraum eine kritische Behandlungsentscheidung getroffen werden: Eignet sich der Patient für eine frühe endgültige operative Versorgung („Early total Care“) seiner Verletzungen? Oder erscheint er zu instabil, sodass zunächst nur unmittelbar lebensrettende Eingriffe zur Blutungs- und Kontaminationskontrolle möglich sind („Damage Control Surgery“)?

Abstract

Trauma triggers complex physiological responses with primary and secondary effects vital to understanding and managing trauma impact. “Damage Control” (DC), a concept adapted from naval practices, refers to abbreviated initial surgical care focused on controlling bleeding and contamination, critical for the survival of severely compromised patients. This impacts anaesthesia procedures and intensive care. “Damage Control Resuscitation” (DCR) is an interdisciplinary approach aimed at reducing mortality in severely injured patients, despite potentially increasing morbidity and ICU duration. Current medical guidelines incorporate DC strategies.

DC is most beneficial for patients with severe physiological injury, where surgical trauma (“second hit”) poses greater risks than delayed treatment. Patient assessment for DC includes evaluating injury severity, physiological reserves, and anticipated surgical and treatment strain. Inadequate intervention can worsen trauma-induced complications like coagulopathy, acidosis, hypothermia, and hypocalcaemia.

DCR focuses on rapidly restoring homeostasis with minimal additional burden. It includes rapid haemostasis, controlled permissive hypotension, early blood transfusion, haemostasis optimization, and temperature normalization, tailored to individual patient needs.

“Damage Control Surgery” (DCS) involves phases like rapid haemostasis, contamination control, temporary wound closure, intensive stabilization, planned reoperations, and final wound closure. Each phase is crucial for managing severely injured patients, balancing immediate life-saving procedures and preparing for subsequent surgeries.

Intensive care post-DCS emphasizes stabilizing patients hemodynamically, metabolically, and coagulopathically while restoring normothermia. Decision-making in trauma care is complex, involving precise patient assessment, treatment prioritization, and team coordination. The potential of AI-based decision support systems is noted for their ability to analyse patient data in real-time, aiding in decision-making through evidence-based recommendations.

Kernaussagen

• Ziel von Damage-Control-Verfahren ist, das Überleben von schwerstverletzten Patienten zu ermöglichen, die sich bereits in einem ausgeprägten Schockzustand befinden. Diese Patienten besitzen keine physiologischen Reserven mehr, um zusätzliche Belastungen durch ausgedehnte operative Eingriffe zu kompensieren.

• Grundlage sind eine schnelle Blutungs- und Kontaminationskontrolle sowie eine abgekürzte chirurgische Versorgung mit temporärem Wundverschluss.

• Danach erfolgt eine weitere Stabilisierung auf der Intensivstation.

• Die Schocktherapie zielt auf die Vermeidung von Koagulopathie, Azidose, Hypothermie und Hypokalzämie ab.

• Besondere Bedeutung besitzen ein angepasster Volumenersatz und permissive Hypotension bis zur Blutungskontrolle unter Beachtung von Kontraindikationen (ZNS-Verletzung). Ebenso ein an der Vollblutzusammensetzung orientiertes Transfusionsregime (EK : FFP : TK = 4 : 4 : 1) sowie der zielgerichtete Einsatz von Gerinnungsprodukten.

• Folgeeingriffe finden erst nach physiologischer Stabilisierung statt.

Schlüsselwörter

Damage Control Resuscitation - Damage Control Surgery - Polytrauma - Schock - Intensivmedizin

Keywords

damage control resuscitation - damage control surgery - multiple trauma - shock - intensive care medicine

Publikationsverlauf

Artikel online veröffentlicht:
24. Juni 2024

• Literatur

• 1 Giannoudis PV. Surgical priorities in damage control in polytrauma. J Bone Joint Surg Br 2003; 85: 478-483
• 2 Nada A, Güsgen C, Schwab R. Damage Control Surgery. Allgemein- und Viszeralchirurgie up2date 2021; 15: 287-304
• 3 Giannoudi M, Harwood P. Damage control resuscitation: lessons learned. Eur J Trauma Emerg Surg 2016; 42: 273-282
• 4 Roberts DC, Bobrovitz N, Zygun DA. et al. Evidence for use of damage control surgery and damage control interventions in civilian trauma patients: a systematic review. World J Emerg Surg 2021; 16: 10
• 5 AWMF online. S3-Leitlinie Polytrauma/Schwerverletzten-Behandlung. AWMF-Register-Nr. 187–023. Version 4.1. Zugriff am 03. April 2024 unter: https://register.awmf.org/de/leitlinien/detail/187–023
• 6 Rossaint R, Afshari A, Bouillon B. et al. The European guideline on management of major bleeding and coagulopathy following trauma: sixth edition. Crit Care 2023; 27: 80
• 7 Milne A, Radhakrishnan A. Biochemical disturbance in damage control resuscitation: mechanisms, management and prognostic utility. Curr Opin Anaesthesiol 2023; 36: 176-182
• 8 Standl T, Annecke T, Cascorbi I. et al. The nomenclature, definition and distinction of types of shock. Dtsch Arztebl Int 2018; 115: 757-768
• 9 Timmermans K, Kox M, Vaneker M. et al. Plasma levels of danger-associated molecular patterns are associated with immune suppression in trauma patients. Intensive Care Med 2016; 42: 551-561
• 10 Torres I Filho. Hemorrhagic shock and the microvasculature. Compr Physiol 2017; 12: 61-101
• 11 Cap AP, Pidcoke HF, Spinella P. et al. Damage Control Resuscitation. Mil Med 2018; 183 (Suppl. 2) 36-43
• 12 Moore EE, Moore HB, Kornblith LZ. et al. Trauma-induced coagulopathy. Nat Rev Dis Primers 2021; 29: 30
• 13 Woolley T, Thompson P, Kirkman E. et al. Trauma Hemostasis and Oxygenation Research Network position paper on the role of hypotensive resuscitation as part of remote damage control resuscitation. J Trauma Acute Care Surg 2018; 84(Suppl. 6S): S3-S13
• 14 AWMF online. S1-Leitlinie Intraoperative klinische Anwendung von hämodynamischem Monitoring bei nicht-kardiochirurgischen Patient:innen. AWMF-Register-Nr. 001–049. Version 1.0. Zugriff am 03. April 2024 unter: https://register.awmf.org/de/leitlinien/detail/001–049
• 15 Bundesärztekammer (BÄK). Querschnitts-Leitlinien (BÄK) zur Therapie mit Blutkomponenten und Plasmaderivaten – Gesamtnovelle 2020. Zugriff am 03. April 2024 unter: https://www.bundesaerztekammer.de/fileadmin/user_upload/_old-files/downloads/pdf-Ordner/MuE/Querschnitts-Leitlinien_BAEK_zur_Therapie_mit_Blutkomponenten_und_Plasmaderivaten-Gesamtnovelle_2020.pdf
• 16 Shakur H, Roberts I, Bautista R. CRASH-2 trial collaborators. et al. Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial. Lancet 2010; 376: 23-32
• 17 Akbari E, Safari S, Hatamabadi H. The effect of fibrinogen concentrate and fresh frozen plasma on the outcome of patients with acute traumatic coagulopathy: A quasi-experimental study. Am J Emerg Med 2018; 36: 1947-1950
• 18 Caspers M, Holle JF, Limper U. et al. Global coagulation testing in acute care medicine: back to bedside?. Hamostaseologie 2022; 42: 400-408
• 19 Vargas M, Garcia A, Caicedo Y. et al. Damage control in the intensive care unit: what should the intensive care physician know and do?. Colomb Med (Cali) 2021; 52: e4174810
• 20 Malbrain MLNG, Marik PE, Witters I. et al. Fluid overload, de-resuscitation, and outcomes of critically ill or injured patients: a systematic review with suggestions for clinical practice. Anaesthesiol Intensive Ther 2014; 46: 361-380
• 21 Duchesne J, Kaplan LJ, Balogh ZJ. et al. Role of permissive hypotension, hypertonic resuscitation and the global increased permeability syndrome in patients with severe haemorrhage: adjuncts to damage control resuscitation to prevent intra-abdominal hypertension. Anaesthesiol Intensive Ther 2015; 47: 143-155